1887

oa South African Journal of Bioethics and Law - The South African clinical trial industry: Implications of problems with the issuing of human tissue export permits : forum

 

Abstract

The National Health Act requires a valid permit before human biological tissue samples are exported from South Africa. However, delays in issuing export permits make it difficult for many researchers and pharmaceutical companies to comply. There are misconceptions about who is responsible for obtaining such a permit. Delays have caused many new trials to start without a permit, and biological samples from ongoing trials have been exported using expired permits. This could have detrimental consequences for the South African trial industry, especially with the country's history of vulnerable populations in developing areas. Medicine Control Council inspections have listed findings related to export permits for several trial sites. Researchers must be aware that it remains their responsibility to apply for such a permit. The most important steps to ensure a smoother approval process are for applicants to () familiarise themselves with the permit issue process and () recognise the importance of correctly completing and signing application forms.

Loading

Article metrics loading...

/content/m_sajbl/6/1/EJC139681
2013-06-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error